What are the brand‑name formulations of doxylamine (doxylamine succinate)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Brand Name Formulations of Doxylamine

Doxylamine succinate is available under several brand names, most notably as Unisom SleepTabs (as a single-ingredient sleep aid) and as Diclegis/Diclectin (in combination with pyridoxine for pregnancy-related nausea and vomiting).

Single-Ingredient Formulations

Doxylamine succinate 25 mg is marketed as an over-the-counter sleep aid under multiple brand names 1:

  • Unisom SleepTabs - the most widely recognized brand name in the United States 1
  • Donormyl - available in France and other markets 2
  • Lidene - another European brand name 2
  • Generic formulations are also widely available 1, 2

These products are indicated for occasional insomnia in adults and are available without prescription 1, 2.

Combination Formulations with Pyridoxine

The delayed-release combination of doxylamine succinate 10 mg and pyridoxine hydrochloride (vitamin B6) 10 mg is available under two primary brand names 3, 4:

  • Diclegis - FDA-approved in the United States in April 2013 specifically for nausea and vomiting of pregnancy (NVP) 5, 3, 4
  • Diclectin - available in Canada since 1979 for the same indication 3, 4

This combination represents the only FDA-approved medication specifically indicated for nausea and vomiting of pregnancy 4. The formulation is available in 10 mg/10 mg and 20 mg/20 mg combinations 6, 7.

Clinical Context

The doxylamine-pyridoxine combination is recommended by the American College of Obstetricians and Gynecologists (ACOG) as first-line pharmacologic therapy for persistent NVP refractory to non-pharmacologic interventions 6. The dosing typically starts with 20 mg/20 mg at bedtime, with potential titration to additional doses in the morning (10 mg/10 mg) and at lunchtime (10 mg/10 mg) based on symptom response 7.

The extensive safety profile of this combination, with studies involving over 200,000 women exposed during the first trimester showing no increased risk of congenital malformations, has earned it FDA Pregnancy Category A status 3, 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.